Illumina announced an agreement to acquire SomaLogic on September 3, 2025, utilizing SomaLogic's technology for new assays.
2 reports, 1 independent
Updated Sep 3
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Illumina announced an agreement to acquire SomaLogic on September 3, 2025, utilizing SomaLogic's technology for new assays.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The acquisition of SomaLogic by Illumina is expanding Illumina's capabilities into proteomics and precision medicine.Sub-event
- Illumina acquired SomaLogic for cash and royalties.Sub-event
Illumina announced agreement to acquire SomaLogic.1 source
Keep exploring
The entities involved
-
Illumina
American company that develops systems for the analysis of genetic variation
Nothing else this week.
-
SomaLogic
company in Boulder, United States
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development Illumina Protein Prep can measure 9500 unique human protein targets, offering new insig
- PR NewswireIllumina Reports Financial Results for Second Quarter of Fiscal Year 2025 Revenue of $1.06 billion for Q2 2025, down 3% from Q2 2024 on both a reported and constant currency basis GAAP operating marg